Work

nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study

Year: 2018

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdy424.076

Authors: D.R. Spigel, R.M. Jotte, S. Ponce Aix, L. Gressot, D. Morgensztern, M. McCleod, M.A. Socinski, D. Daniel, O. Juan-Vidal, E.S. Kim, H.J. West, T. Chen, R. Bhore, T.J. Ong, C. Gridelli, M. Thomas

Institutions: Sarah Cannon, Rocky Mountain Cancer Centers, Spanish National Cancer Research Centre, Washington University in St. Louis, Florida Hospital Cancer Institute, Tennessee Oncology, Hospital Universitari i Politècnic La Fe, Levine Cancer Institute, Swedish Medical Center, Celgene (United States), Azienda Ospedaliera S.Giuseppe Moscati, University Hospital Heidelberg, German Center for Lung Research

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Celgene, Genentech

OpenAlex ID: W2898116683

FWCI: 0.188

Cites:

Cited by: 1

Related to: 10